Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

Wade, Derick T, Makela, Petra, Robson, Philip, House, Heather, Bateman, Cynthia · 2004 · Multiple Sclerosis Journal

Abstract

The objective was to determine whether a cannabis-based medicinal extract (CBME) benefits a range of symptoms due to multiple sclerosis (MS). A parallel group, double-blind, randomized, placebo-controlled study was undertaken in three centres, recruiting 160 outpatients with MS experiencing significant problems from at least one of the following: spasticity, spasms, bladder problems, tremor or pain. The interventions were oromucosal sprays of matched placebo, or whole plant CBME containing equal amounts of delta-9- tetrahydrocannabinol (THC) and cannabidiol (CBD) at a dose of 2.5- 120 mg of each daily, in divided doses. The primary outcome measure was a Visual Analogue Scale (VAS) score for each patient’s most troublesome symptom. Additional measures included VAS scores of other symptoms, and measures of disability, cognition, mood, sleep and fatigue. Following CBME the primary symptom score reduced from mean (SE) 74.36 (11.1) to 48.89 (22.0) following CBME and from 74.31 (12.5) to 54.79 (26.3) following placebo [ns]. Spasticity VAS scores were significantly reduced by CBME (Sativex) in comparison with placebo (P- 0.001). There were no significant adverse effects on cognition or mood and intoxication was generally mild.

Overview

Integrity signals

Registry

Crossref · 10.1191/1352458504ms1082oa

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Cited by

See all 652

Metadata

Authors
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C.
Affiliations
  • Oxford Centre for Enablement, Windmill Road, Oxford OX3 7LD, UK, The Research Centre, Unit G1, The Magdalen Centre, The Oxford Science Park, Oxford OX4 4GA, UK,
  • Oxford Centre for Enablement, Windmill Road, Oxford OX3 7LD, UK, The Research Centre, Unit G1, The Magdalen Centre, The Oxford Science Park, Oxford OX4 4GA, UK
  • University of Oxford (GB)
Corresponding author
Wade, Derick T
Venue
Multiple Sclerosis Journal
Published
2004-08
Volume
10
Issue
4
Pages
434-441
ISSN
  • 1352-4585 (ISSN-L)
  • 1477-0970
OpenAlex
W2110690684
Cited by
589
References
35
Citations by year
2026: 15 · 2025: 36 · 2024: 21 · 2023: 23 · 2022: 42 · 2021: 27 · 2020: 35 · 2019: 27 · 2018: 38 · 2017: 29 · 2016: 25 · 2015: 25 · 2014: 28 · 2013: 20 · 2012: 23
FWCI
18.84
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Multiple Sclerosis Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
GW Pharmaceuticals
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
Keywords
multiple sclerosis, Sativex, delta-9-tetrahydrocannabinol, cannabidiol, spasticity, spasms, pain, tremor, bladder dysfunction, symptom relief, oromucosal spray, cognitive effects, mood, fatigue, sleep
MeSH terms
Aerosols, Urinary Bladder Diseases, Cannabidiol, Cannabis, Disability Evaluation, Dose-Response Relationship, Drug, Double-Blind Method, Humans, Mouth Mucosa, Multiple Sclerosis, Muscle Spasticity, Pain, Pain Measurement, Plant Extracts, Dronabinol, Tremor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. https://app.cochat.ai/papers/10.1191/1352458504ms1082oa
The paper
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004). Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Multiple Sclerosis Journal. https://doi.org/10.1191/1352458504ms1082oa

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.